Skip to main content

Thrombosis in Cancer Patients (TCP) Project

Description

This compendium contains SOPs contributed by the Thrombosis in Cancer Patients (TCP) study. The overall objective of the TCP study is to guide the standardization of methods and approaches used for measuring biomarkers of thrombosis. In particular, the study was designed to identify the impact of three pre-analytic variables (delay to centrifugation, freeze/thaw cycles, and delay to testing) on analysis of twelve plasma biomarkers in cancer patients and non-cancer control donors using standardized methodologies. The SOPs in this compendium are a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).

Sources

  • TCP Project

Standard Operating Procedures (16)

TitleVersionSource
Blood Sample Collection SOP
TCP Project
Factor Assay – VIII, IX, XI, XII
TCP Project
D-Dimer HS
TCP Project
Prothrombin Fragment 1+2 ELISA
TCP Project
Soluble P Selectin ELISA
TCP Project
Plasma DNA Assay
TCP Project
Nucleosome ELISA
TCP Project
Myeloperoxidase assay
TCP Project
PAI-1 ELISA
TCP Project
Plasmin-Antiplasmin ELISA
TCP Project
Blood Sample Processing, Storage and Shipping
TCP Project
Soluble Thrombomodulin
TCP Project
IL-6 ELISA
TCP Project
Soluble Tissue Factor
TCP Project
IL-6 ELISA (New Kit)
TCP Project
Soluble P Selectin ELISA (DPSE100)
TCP Project